Natural Health Trends Corp. (NHTC) Key Metrics
NHTC valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $8.3M
- Enterprise value
- −$2.4M
- P/E (TTM)
- — 10-yr median 71.2
- Forward P/E
- 13.4
- PEG ratio
- 13.45
- Price / sales
- 0.2 10-yr median 0.9
- Price / book
- 0.6 10-yr median 1.5
- EV / EBITDA
- 13.8 10-yr median 2.8
- Dividend yield
- 41.24% $0.40 a year
- Beta
- 1.00
NHTC key metrics, 2017–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNHTC valuation Price multiples at each fiscal year-end price.
Price / sales−27.7%
0.9
2025 · hover or tap a bar for each year
20172025
Price / book−6.1%
1.5
2025 · hover or tap a bar for each year
20172025
Free cash flow yield−10.6 pts
−17.1%
2025 · hover or tap a bar for each year
20172025
NHTC returns How much profit the business earns on the capital it uses.
Return on equity−4.7 pts
−3.1%
2025 · hover or tap a bar for each year
20172025
Return on assets−2.8 pts
−1.9%
2025 · hover or tap a bar for each year
20172025
Free cash flow margin−7.3 pts
−15.2%
2025 · hover or tap a bar for each year
20172025
Asset turnover+22.9%
0.85
2025 · hover or tap a bar for each year
20172025
NHTC per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−7.5%
$3.46
2025 · hover or tap a bar for each year
20172025
Earnings per share
−$0.08
2025 · hover or tap a bar for each year
20172025
Free cash flow per share
−$0.53
2025 · hover or tap a bar for each year
20172025
Book value per share−28.8%
$2.04
2025 · hover or tap a bar for each year
20172025
Dividends per share−0.1%
$0.80
2025 · hover or tap a bar for each year
20172025
Shares outstanding+0.1%
11.5M
2025 · hover or tap a bar for each year
20172025
NHTC financial health Debt, liquidity and how easily interest is covered.
Debt / equity+66.3%
0.13
2025 · hover or tap a bar for each year
20172025
Net debt+$15.6M
−$25.7M
2025 · hover or tap a bar for each year
20172025
Current ratio+1.9%
2.50
2025 · hover or tap a bar for each year
20172025
Debt / assets+70.8%
0.08
2025 · hover or tap a bar for each year
20172025
NHTC efficiency & capital use Working capital cycle and where the cash goes.
Days of inventory−31 days
92 days
2025 · hover or tap a bar for each year
20172025
Days payables outstanding−6 days
25 days
2025 · hover or tap a bar for each year
20172025
Capex / revenue0.0 pts
0.2%
2025 · hover or tap a bar for each year
20172025
NHTC valuation history
Fiscal year-endToday10-year median
NHTC returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NHTC debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NHTC cash returned to shareholders
DividendsBuybacksFree cash flow
NHTC price vs earnings per share
Share price at year-endEPS (right axis)
NHTC key metrics
2017–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $35.5M | $53.1M | $67.1M | $39.2M | $77.2M | $56.9M | $58.5M | $209.3M | $171.1M | — |
| Enterprise value | $9.8M | $11.8M | $14.4M | −$26.4M | −$3.4M | −$31.5M | −$34.3M | $95.5M | $54.9M | — |
| P/E ratio | — | 92.8 | 118.2 | 125.2 | 71.2 | 67.5 | — | 6.7 | 7.3 | — |
| Price / sales | 0.9 | 1.2 | 1.5 | 0.8 | 1.3 | 0.9 | 0.8 | 1.1 | 0.9 | — |
| Price / book | 1.5 | 1.6 | 1.6 | 0.8 | 1.3 | 0.8 | 0.8 | 2.3 | 1.9 | — |
| Price / free cash flow | — | — | — | — | 97.6 | 34.0 | — | 7.1 | 6.5 | — |
| Price / operating cash flow | — | — | — | — | 76.0 | 30.2 | — | 7.0 | 6.4 | — |
| EV / sales | 0.2 | 0.3 | 0.3 | -0.5 | -0.1 | -0.5 | -0.4 | 0.5 | 0.3 | — |
| EV / EBITDA | — | 15.7 | — | — | — | — | — | 2.8 | 1.3 | — |
| EV / free cash flow | — | — | — | — | — | — | — | 3.2 | 2.1 | — |
| Earnings yield | −2.5% | 1.1% | 0.8% | 0.8% | 1.4% | 1.5% | −9.6% | 14.8% | 13.8% | — |
| Free cash flow yield | −17.1% | −6.5% | −6.4% | −12.7% | 1.0% | 2.9% | −32.2% | 14.1% | 15.4% | — |
| Dividend yield | 25.9% | 17.4% | 13.7% | 23.3% | 11.8% | 16.1% | 12.6% | 15.1% | 10.1% | — |
| Shareholder yield (dividends + buybacks) | 25.9% | 17.4% | 13.7% | 23.3% | 11.8% | 17.0% | 29.9% | 15.1% | 10.1% | — |
| Share price at fiscal year-end | $3.09 | $4.62 | $5.86 | $3.43 | $6.76 | $4.98 | $5.38 | $18.49 | $15.19 | $23.90 |
| Per share | ||||||||||
| Revenue per share | $3.46 | $3.74 | $3.83 | $4.30 | $5.25 | $5.43 | $7.14 | $16.96 | $17.53 | — |
| Earnings per share | −$0.08 | $0.05 | $0.05 | $0.03 | $0.09 | $0.07 | −$0.52 | $2.74 | $2.09 | — |
| Operating cash flow per share | −$0.52 | −$0.29 | −$0.37 | −$0.42 | $0.09 | $0.17 | −$1.71 | $2.63 | $2.36 | — |
| Free cash flow per share | −$0.53 | −$0.30 | −$0.38 | −$0.44 | $0.07 | $0.15 | −$1.73 | $2.61 | $2.34 | — |
| Cash per share | $2.51 | $3.82 | $4.90 | $6.10 | $7.34 | $8.09 | $8.83 | $11.72 | $12.01 | — |
| Book value per share | $2.04 | $2.86 | $3.63 | $4.39 | $5.21 | $5.93 | $6.90 | $7.94 | $8.04 | — |
| Tangible book value per share | $2.04 | $2.86 | $3.63 | $4.39 | $5.21 | $5.93 | $6.90 | $7.63 | $7.73 | — |
| Dividends per share | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.80 | $0.68 | $2.78 | $1.53 | — |
| Capex per share | $0.01 | $0.00 | $0.00 | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | — |
| Debt per share | $0.27 | $0.23 | $0.30 | $0.36 | $0.28 | $0.34 | $0.30 | $1.67 | $1.69 | — |
| Shares outstanding | 11.5M | 11.5M | 11.5M | 11.4M | 11.4M | 11.4M | 10.9M | 11.3M | 11.3M | — |
| Change in shares outstanding | +0.1% | +0.3% | +0.3% | −0.0% | 0.0% | +5.1% | −3.9% | +0.5% | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −3.1% | 1.5% | 1.2% | 0.6% | 1.7% | 1.2% | −6.8% | 34.4% | 0.4% | 16.9% |
| Return on invested capital (ROIC) | — | — | — | — | — | — | — | — | — | 16.8% |
| Return on assets (ROA) | −1.9% | 0.9% | 0.7% | 0.3% | 1.1% | 0.8% | −4.1% | 19.6% | 0.1% | 5.8% |
| Return on tangible assets | −2.3% | 1.0% | 0.8% | 0.4% | 1.1% | 0.8% | −4.7% | 20.1% | 15.1% | 4.5% |
| Free cash flow margin | −15.2% | −8.0% | −9.8% | −10.2% | 1.3% | 2.7% | −24.3% | 15.4% | 13.3% | 15.1% |
| Income quality (OCF / net income) | — | −5.89 | −7.53 | −15.50 | 0.94 | 2.24 | — | 0.96 | 1.13 | 2.32 |
| Financial health | ||||||||||
| Total debt | $3.1M | $2.6M | $3.5M | $4.1M | $3.2M | $3.9M | $3.2M | $18.9M | $19.1M | $18.87B |
| Cash & short-term investments | $28.9M | $43.9M | $56.2M | $69.7M | $83.8M | $92.4M | $96.0M | $132.7M | $135.3M | $14.18B |
| Net debt | −$25.7M | −$41.3M | −$52.7M | −$65.5M | −$80.7M | −$88.4M | −$92.8M | −$113.7M | −$116.2M | $4.69B |
| Debt / equity | 0.13 | 0.08 | 0.08 | 0.08 | 0.05 | 0.06 | 0.04 | 0.21 | 0.21 | 1.46 |
| Debt / assets | 0.08 | 0.05 | 0.05 | 0.05 | 0.03 | 0.04 | 0.03 | 0.12 | 0.12 | 0.50 |
| Net debt / EBITDA | — | −54.99 | — | −81.32 | −44.60 | −81.95 | — | −3.33 | −2.67 | — |
| Current ratio | 2.50 | 2.45 | 3.21 | 3.79 | 3.79 | 4.64 | 4.12 | 3.49 | 3.61 | 5.58 |
| Quick ratio | 2.35 | 2.29 | 3.00 | 3.57 | 3.58 | 4.46 | 3.88 | 3.20 | 3.41 | 5.03 |
| Interest coverage | — | — | — | -0.3 | 25.8 | 0.8 | -3.3 | — | — | — |
| Working capital | $20.5M | $30.2M | $44.2M | $57.1M | $68.8M | $78.2M | $82.1M | $107.1M | $109.3M | $15.29B |
| Invested capital | −$2.3M | −$8.4M | −$11.1M | −$15.4M | −$21.2M | −$20.7M | −$17.8M | −$23.9M | −$25.6M | $17.64B |
| Tangible asset value | $23.4M | $32.9M | $41.6M | $50.2M | $59.5M | $67.7M | $75.1M | $86.3M | $87.1M | −$508.0M |
| Net current asset value | $19.2M | $28.5M | $36.7M | $44.9M | $54.6M | $61.5M | $64.9M | $82.1M | $82.3M | −$6.15B |
| Graham number | — | $1.79 | $2.01 | $1.65 | $3.34 | $3.14 | — | $22.13 | $19.46 | — |
| Graham net-net per share | $1.30 | $2.01 | $2.69 | $3.48 | $4.17 | $4.90 | $5.33 | $6.24 | $6.26 | — |
| Capital allocation | ||||||||||
| Dividends paid | $9.2M | $9.2M | $9.2M | $9.1M | $9.1M | $9.1M | $7.3M | $31.5M | $17.2M | $677.0M |
| Share buybacks (net) | — | — | — | — | — | $553,000 | $10.1M | — | — | $0 |
| Dividend payout ratio | — | — | — | — | 842.2% | — | — | 101.5% | 73.0% | 61.5% |
| Dividends + buybacks / free cash flow | — | — | — | — | — | 578.9% | — | 106.8% | 65.4% | 37.1% |
| Capex / revenue | 0.2% | 0.1% | 0.1% | 0.3% | 0.4% | 0.3% | 0.2% | 0.1% | 0.1% | 6.0% |
| Capex / operating cash flow | — | — | — | — | 22.1% | 11.2% | — | 0.7% | 1.0% | 28.5% |
| Capex / depreciation | 0.62 | 0.44 | 0.28 | 0.70 | 0.75 | 0.51 | 0.49 | 0.50 | 0.52 | 0.67 |
| Stock-based compensation / revenue | 0.3% | 0.3% | 0.4% | 1.2% | 1.3% | — | 2.3% | — | 0.0% | — |
| R&D / revenue | — | — | — | — | — | — | — | — | — | 6.4% |
| SG&A / revenue | 78.1% | 77.0% | 80.2% | 74.8% | 72.4% | 71.6% | 80.9% | 61.9% | 58.6% | 27.6% |
| Efficiency | ||||||||||
| Days sales outstanding | — | — | — | 2.3 | 0.0 | 8.4 | 6.7 | 0.0 | 1,611.0 | 26.3 |
| Days of inventory on hand | 92.2 | 123.5 | 144.0 | 141.0 | 109.9 | 109.4 | 168.6 | 95.3 | 8,625.1 | 54.3 |
| Days payables outstanding | 25.1 | 30.8 | 29.4 | 22.6 | 16.3 | 13.5 | 21.0 | 15.7 | 14,832.1 | 93.2 |
| Cash conversion cycle (days) | — | — | — | 120.6 | 93.6 | 104.3 | 154.3 | 79.6 | -4,596.0 | -12.6 |
| Receivables turnover | — | — | — | 162.16 | 60,005,000.00 | 43.38 | 54.24 | 191,910,000.00 | 0.23 | 13.87 |
| Payables turnover | 14.51 | 11.86 | 12.42 | 16.12 | 22.39 | 26.97 | 17.40 | 23.28 | 0.02 | 3.92 |
| Inventory turnover | 3.96 | 2.96 | 2.53 | 2.59 | 3.32 | 3.34 | 2.17 | 3.83 | 0.04 | 6.73 |
| Asset turnover | 0.85 | 0.69 | 0.58 | 0.54 | 0.59 | 0.55 | 0.56 | 1.21 | 0.01 | 0.64 |
| Average receivables | — | — | — | $303,000 | $1 | $1.4M | $1.4M | $1 | $872.0M | $872.0M |
| Average payables | $725,000 | $942,500 | $900,000 | $785,500 | $670,500 | $630,000 | $1.2M | $1.7M | $1.57B | $1.57B |
| Average inventory | $2.7M | $3.8M | $4.4M | $4.9M | $4.5M | $5.1M | $9.3M | $10.3M | $913.2M | $914.6M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.2% | 2.2% | 35.7% |
Computed from NHTC's annual financial statements (latest annual report filed February 20, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NHTC valuation and financial ratios
Natural Health Trends earned a return on equity of −3.1% in fiscal 2025. It ended the year with $3.1 million of debt and $28.9 million in cash and short-term investments, a net cash position of $25.7 million. It returned $9.2 million to shareholders: $9.2 million in dividends and $0 in share buybacks.
See the NHTC income statement, the NHTC chart for price history, or the NHTC stock overview for the latest quote and news.
NHTC key metrics FAQ
What is Natural Health Trends's return on equity?
Natural Health Trends's return on equity (ROE) was −3.1% in fiscal 2025: net income of -$0.9 million on average shareholders' equity of $28.2 million.
How much debt does Natural Health Trends have?
Natural Health Trends had total debt of $3.1 million at the end of fiscal 2025, a debt-to-equity ratio of 0.13 and more cash than debt.
What is Natural Health Trends's dividend yield?
Natural Health Trends's forward dividend yield is 41.24%. Natural Health Trends paid $9.2 million in dividends in fiscal 2025 ($0.80 per share), a payout ratio of —.
What is Natural Health Trends's free cash flow yield?
Natural Health Trends generated -$6.1 million of free cash flow in fiscal 2025, a free cash flow yield of −17.1% on its market value at year-end ($35.5 million).
What is Natural Health Trends's current ratio?
Natural Health Trends's current ratio was 2.50 at the end of fiscal 2025: current assets were 2.50 times current liabilities.